Mutations in the BRAF-V600E gene occur in approximately 45% of papillary thyroid cancers [65], while mutations in the RAS and ALK genes are frequently found [66–68] These mutations drive mTOR pathway activation and lead to thyroid tumourigenesis [69]. Here, ALK is linked to thyroid gland papillary carcinoma.